摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-3-cyano-5-methyl-4-phenylpyrrole | 54153-52-5

中文名称
——
中文别名
——
英文名称
2-amino-3-cyano-5-methyl-4-phenylpyrrole
英文别名
2-amino-5-methyl-4-phenyl-1H-pyrrole-3-carbonitrile
2-amino-3-cyano-5-methyl-4-phenylpyrrole化学式
CAS
54153-52-5
化学式
C12H11N3
mdl
——
分子量
197.239
InChiKey
XBTFZXGMLHPKFI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    466.9±45.0 °C(Predicted)
  • 密度:
    1.23±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    65.6
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    2-重氮吡咯的吡咯并[2,1-c] [1,2,4]三嗪:合成和抗增殖活性。
    摘要:
    吡咯并[2,1-c] [1,2,4]三嗪4a-g直接从2-重氮吡咯1a和b与β-二酮,β-腈和β-二腈的钠盐反应而获得。仅当2-重氮吡咯与氰基乙酸乙酯偶联时,才可能与吡咯并三嗪一起分离出中间3,后者又环化成标题环系统。美国国家癌症研究所评估了吡咯并三嗪4a-e对60种人类癌细胞系的细胞毒性活性,其中一些表现出对多种癌细胞系生长的抑制作用,通常在10(-5)M水平在某些情况下,浓度为微摩尔。
    DOI:
    10.1016/s0223-5234(02)01339-9
点击查看最新优质反应信息

文献信息

  • Pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3h)-ones, a new class of azolotetrazines with potent antitumor activity
    作者:Patrizia Diana、Paola Barraja、Antonino Lauria、Alessandra Montalbano、Anna Maria Almerico、Gaetano Dattolo、Girolamo Cirrincione
    DOI:10.1016/s0968-0896(03)00145-7
    日期:2003.5.29
    Pyrrolo[2,1-d][1,2,3,5]tetrazinones 10a-o, compounds that hold the deaza skeleton of the antitumor drug temozolomide, were prepared by reaction of 2-diazopyrroles 9 and isocyanates. Such a synthetic route represents, among those leading to azolo-tetrazinones reported so far, the only possible one since attempts to cyclize to the title ring system 2-amino-1-carbamoylpyrroles 11 or the mono substituted 2-triazenopyrrole 12 failed. Compounds 10 were screened at the National Cancer Institute (NCI) for their activity against a panel of about 60 human tumor cell lines. Most of them possess remarkable antineoplastic activity having 6150 values in the low micromolar or sub-micromolar range and reaching, in the case of compound 10d, nanomolar concentrations. The most sensitive cell lines were MDA-N and MDA-MB-435 of the breast sub-panel, and SR, K-562, HL60 (TB) and CCRF-CEM of the leukaemia sub-panel. SAR evaluation and COMPARE computations indicate, for compounds 10, a mechanism of action different from that of temozolomide. (C) 2003 Elsevier Science Ltd. All rights reserved.
  • Neue Synthese von substituierten 4-Amino-chinazolinen und deren Heteroanalogen
    作者:K. Gewald、H. Sch�fer、K. Eckert、T. Jeschke
    DOI:10.1002/prac.19963380144
    日期:——
    N-Chloracetyl-anthranilonitriles react with potassium thiocyanate in the presence of alcohol to the (4-amino-quinazolin-2-yl-thio)-acetic acid ester (5). In the presence of water or primary amine the acetic acid derivative (6) or the acetic acid amide derivatives (7) are obtained. 2,4-Diamino-quinazolines (8) arise if vigorous reaction conditions are employed. With 2-chloracetylamino-cyclopent-1-en-carbonitrile as starting material the pyrimidines (11) are formed from the reaction with potassium thiocyanate. Analogously, (4-pyrimidyl-2-yl-seleno)-acetic acid ester (12) and (thiazolo[4,5d]pyrimid-2-yl-seleno)-acetic acid derivatives (16)can be prepared with potassium selenocyanate. N-Chloracetyl derivatives of 5-membered heterocycles with enamino-nitrile structure (13, 15, 18, 20) react with potassium thiocyanate to yield thieno[2,3-d]-, thiazolo[4,5-d]-, pyrrolo[2,3-d]-, furo[2,3-d]and pyrazolo[4,3-d]pyrimidines (14, 16, 19a, 19b, 21).
  • Pyrrolo[2,1-d][1,2,3,5]tetrazines, a New Class of Azolotetrazines Related to the Antitumor Drug Temozolomide
    作者:Patrizia Diana
    DOI:10.1055/s-1999-3628
    日期:1999.12
  • 5,6-Condensed 3-nitropyridines from heterocyclic amines and nitromalonaldehyde
    作者:H. Sch�fer、K. Gewald、M. Schmidt
    DOI:10.1007/bf00515347
    日期:1983.11
  • SHEFER, X.;GEVALD, K.;SHMIDT, M., XIMIYA GETEROTSIKL. SOEDIN., 1983, N 11, 1471-1475
    作者:SHEFER, X.、GEVALD, K.、SHMIDT, M.
    DOI:——
    日期:——
查看更多